Case Report
Hepatitis B Virus Reactivation Induced by Infliximab Administration in a Patient with Crohn’s Disease
Table 2
HBV markers in patients treated with infliximab.
| Age | Sex | | HBsAg | Anti-HBs
| Anti-HBc s/co | HBV reactivation | Entecavir |
| 47 | F | Crohn | | | | | | 54 | F | Crohn | | | 6.41 | | | 47 | M | Crohn | | | 1.62 | | | 55 | F | Crohn | | | 0.9 | | | 64 | F | UC | | | 0.09 | | | 19 | M | Crohn | | | 0.05 | | | 34 | M | Crohn | | | 0.11 | | | 52 | F | UC | | | 0.07 | | | 43 | M | Crohn | | | 0.09 | | | 38 | M | Behçet | | | 0.11 | | | 52 | M | UC | | | 0.08 | | | 18 | F | Crohn | | | 0.05 | | | 42 | M | Crohn | | | 0.15 | | | 41 | M | UC | | | 0.07 | | | 23 | M | Crohn | | | 0.14 | | |
|
|
Crohn: Crohn’s disease, UC: ulcerative colitis, Behçet: Behçet’s disease, M: male, F: female.
|